Communicating the promise for ocular gene therapies: Challenges and recommendations

American Journal of Ophthalmology

Volumn 160, Issue 3, 2015, Pages 408-415.e2

  Benjaminy, Shelly ^a   Kowal, Stephanie P ^a   MacDonald, Ian M ^b   Bubela, Tania ^a  

^a Edmonton Clinic Health Academy   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

AGE RELATED MACULAR DEGENERATION; BIOLOGICAL THERAPY; CHOROIDEREMIA; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG SAFETY; DRUG TOLERABILITY; GENE MUTATION; GENE THERAPY; GENETIC SCREENING; HUMAN; LEBER CONGENITAL AMAUROSIS; LEBER HEREDITARY OPTIC NEUROPATHY; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; RETINOPATHY; RETINOSCHISIS; REVIEW; STARGARDT DISEASE; TREATMENT OUTCOME; USHER SYNDROME; VISION; VISUAL IMPAIRMENT; DOCTOR PATIENT RELATION; EYE DISEASES; MEDICAL INFORMATION; PATIENT EDUCATION; PATIENT PARTICIPATION;

EYE DISEASES; GENETIC THERAPY; HEALTH COMMUNICATION; HUMANS; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS;

EID: 84939258801     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2015.05.026     Document Type: Article

References (56)

1. J. Kimmelman Gene Transfer and the Ethics of First-in-Human Research: Lost in Translation 2009 Cambridge University Press New York 1 205
2. J.W.B. Bainbridge, A.J. Smith, S.S. Barker, and et al. Effect of gene therapy on visual function in Leber's congenital amaurosis New Engl J Med 358 21 2008 2231 2239
3. W.W. Hauswirth, T.S. Aleman, S. Kaushal, and et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial Hum Gene Ther 19 2008 979 990
4. A.M. Maguire, F. Simonelli, E.A. Pierce, and et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis New Engl J Med 358 21 2008 2240 2248
5. J. Kaplan Leber congenital amaurosis: from darkness to spotlight Ophthalmic Genet 29 3 2008 92 98
6. J. Bennett, M. Ashtari, J. Wellman, and et al. AAV2 gene therapy readministration in three adults with congenital blindness Sci Transl Med 4 120 2012 120ra115
7. A.M. Maguire, K.A. High, A. Auricchio, and et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial Lancet 374 9701 2009 1597 1605
8. A.P. Wojno, E.A. Pierce, and J. Bennett Seeing the light Sci Transl Med 5 175 2013 175fs8
9. A.V. Cideciyan, S.G. Jacobson, W.A. Beltran, and et al. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement Proc Natl Acad Sci U S A 110 6 2013 E517 E525
10. S.G. Jacobson, A.V. Cideciyan, A.J. Roman, and et al. Improvement and decline in vision with gene therapy in childhood blindness N Engl J Med 372 20 2015 1920 1926
11. J.W.B. Bainbridge, M.S. Mehat, V. Sundaram, and et al. Long-term effect of gene therapy on Leber's congenital amaurosis N Engl J Med 372 20 2015 1887 1897
12. Kaiser J. Gene therapy for blindness may fade with time. Available at http://news.sciencemag.org/biology/2015/05/gene-therapy-blindness-may-fade-time. Accessed May 17, 2015.
13. I. Seitz, A. Zhour, S. Kohl, and et al. Multimodal assessment of choroideremia patients defines pre-treatment characteristics Graefes Arch Clin Exp Ophthalmol 2015 10.1007/s00417-015-2976-4
14. R.E. MacLaren, M. Groppe, A.R. Barnard, and et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial Lancet 383 9923 2014 1129 1137
15. P. Melillo, L. Pecchia, F. Testa, S. Rossi, J. Bennett, and F. Simonelli Pupillometric analysis for assessment of gene therapy in Leber congenital amaurosis patients Biomed Eng Online 11 2012 40
16. A.V. Cideciyan, G.K. Aguirre, S.G. Jacobson, and et al. Pseudo-fovea formation after gene therapy for RPE65-LCA Invest Ophthalmol Vis Sci 56 1 2014 526 537
17. S.G. Jacobson, A.V. Cideciyan, R. Ratnakaram, and et al. Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in fifteen children and adults followed up to three years Arch Ophthalmol 130 1 2012 9 24
18. M. Zallocchi, K. Binley, Y. Lad, and et al. EIAV-based retinal gene therapy in the shaker1 mouse model for Usher syndrome type 1B: development of UshStat PLoS One 9 4 2014 e94272
19. M. Brodie, E.C. Hamel, D.E. Altman, R.J. Blendon, and J.M. Benson Health news and the American public, 1996-2002 J Health Polit Policy Law 28 5 2003 927 950
20. M. Hochman, S. Hochman, D. Bor, and D. McCormick News media coverage of medication research: reporting pharmaceutical company funding and use of generic medication names JAMA 300 13 2008 1544 1550
21. W.Y. Chou, Y. Hunt, E. Beckjord, R. Moser, and B. Hesse Social media use in the United States: implications for health communication J Med Internet Res 11 4 2009 e48
22. M.C. Nisbet, and R.K. Goidel Understanding citizen perceptions of science controversy: bridging the ethnographic - survey research divide Public Understand Sci 16 4 2007 421 440
23. T. Bubela, M.C. Nisbet, R. Borchelt, and et al. Science communication reconsidered Nat Biotechnol 27 6 2009 514 518
24. J. Kitzinger, and C. Williams Forecasting science futures: legitimising hope and calming fears in the embryo stem cell debate Soc Sci Med 61 3 2005 731 740
25. S. Benjaminy, and T. Bubela Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications BMC Med Ethics 15 1 2014 58
26. E. Héon My child has Leber congenital amaurosis: why is he/she not eligible for gene therapy trials? J AAPOS 13 6 2009 533 534
27. W.I. Davies Challenges using diagnostic next-generation sequencing in the clinical environment for inherited retinal disorders Per Med 11 1 2014 99 111
28. F. Wang, H. Wang, H.F. Tuan, and et al. Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements Hum Genet 133 3 2014 331 345
29. J.E. Capasso The cost of genetic testing for ocular disease: who pays? Curr Opin Ophthalmol 25 5 2014 394 399
30. M. McAllister, K. Payne, R. MacLeod, S. Nicholls, D. Donnai, and L. Davies Patient empowerment in clinical genetics services J Health Psychol 13 7 2008 895 905
31. M. McAllister, A.M. Wood, G. Dunn, S. Shiloh, and C. Todd The genetic counseling outcome scale: a new patient-reported outcome measure for clinical genetics services Clin Genet 79 5 2011 413 424
32. R. Kravitz, and R. Bell Media, messages, and medication: strategies to reconcile what patients hear, what they want, and what they need from medications BMC Med Inform Decis Mak 13 Suppl 3 2013 S5
33. J. Kimmelman Ethics of cancer gene transfer clinical research Methods Mol Biol 542 2009 423 445
34. S. Benjaminy, I. MacDonald, and T.M. Bubela "Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials Genet Med 16 5 2014 379 385
35. S. Horng, and C. Grady Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, & therapeutic optimism IRB 25 1 2003 11 16
36. M. Hay, D.W. Thomas, J.L. Craighead, C. Economides, and J. Rosenthal Clinical development success rates for investigational drugs Nat Biotechnol 32 1 2014 40 51
37. F. Testa, A.M. Maguire, S. Rossi, and et al. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital amaurosis type 2 Ophthalmology 120 6 2013 1283 1291
38. Foundation Fighting Blindness. Clinical Trials. Available at http://www.ffb.ca/patient-resources/clinical-trials.html?PHPSESSID=bccf9afa062d43e53523a1c7cfee6a42. Accessed March 17, 2015.
39. T.M. Bubela, and T.A. Caulfield Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers CMAJ 170 9 2004 1399 1407
40. J.M. Wilson Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency Mol Genet Metab 96 4 2009 151 157
41. R. Lewis The Forever Fix: Gene Therapy and the Boy Who Saved It 2012 St. Martin's Press New York 1 323
42. R.H. Glassman, and A.Y. Sun Biotechnology: identifying advances from the hype Nat Rev Drug Discov 3 2 2004 177 183
43. J. Kimmelman The ethics of human gene transfer Nat Rev Genet 9 3 2008 239 244
44. T. Bubela, M. Li, M. Hafez, M. Bieber, and H. Atkins Is belief larger than fact: expectations, optimism and reality for translational stem cell research BMC Med 10 1 2012 133
45. Cahill R. Scientists discover gene tied to profound vision loss. Available at https://www.uth.edu/media/story.htm?id=f1d67f08-4d4c-40a8-a342-4bbef5d5e028. Accessed May 17, 2015.
46. F. Marlhens, C. Bareil, J.M. Griffoin, and et al. Mutations in RPE65 cause Leber's congenital amaurosis Nat Genet 17 2 1997 139 141
47. A.R. Pariser, D.J. Slack, L.J. Bauer, C.A. Warner, and L.A. Tracy Characteristics of rare disease marketing applications associated with FDA product approvals 2006-2010 Drug Discov Today 17 15-16 2012 898 904
48. Timmerman L. Gene therapy lurches ahead, sees thorny future questions on price. Available at http://www.xconomy.com/national/2014/01/27/gene-therapy-lurches-ahead-sees-thorny-future-questions-on-price/. Accessed March 23, 2015.
49. T. Bubela, and C. McCabe Value-engineered translation for regenerative medicine: developing bioetherapeutics that align with health-system needs Am J Manag Care Diabetes 22 Suppl 1 2014 307 312
50. T. Leber Über Retinitis pigmentosa und angeborene Amaurose Archiv für Ophthalmologie 15 3 1869 1 25
51. G.M. Aclend, G.D. Aguirre, J. Ray, and et al. Gene therapy restores vision in a canine model of childhood blindness Nat Genet 28 2001 92 95
52. A.V. Cideciyan, W.W. Hauswirth, T.S. Aleman, and et al. Vision 1 year after gene therapy for Leber's congenital amaurosis New Engl J Med 361 7 2009 725 727
53. RetNet. Genes and mapped loci causing retinal diseases. Available at https://sph.uth.edu/RetNet/disease.htm. Accessed May 17, 2015.
54. J.-A. Sahel, and B. Roska Gene therapy for blindness Annu Rev Neurosci 36 2013 467 488
55. J.E. Groopman A strategy for hope: a commentary on necessary collusion J Clin Oncol 23 13 2005 3151 3152
56. R. McGowan Beyond the disorder: one parent's reflection on genetic counselling J Med Ethics 25 1999 195 199